Concepedia

Publication | Open Access

A combination of pre-infusion serum ferritin, CRP and IL-6 predicts outcome in relapsed/refractory multiple myeloma patients treated with CAR-T cells

DOIFull Paper Access

28

Citations

28

References

2023

Year

Yang Liu, Xingxing Jie, Nian Li, Ying Wang, Congyue Wang, Jin Ma, Jingjing Jiang, Qingyun Wu, Jianlin Qiao, Wei Chen,
Frontiers in Immunology

Abstract

Our results suggest that patients with elevated inflammation markers before CAR-T cell infusion are more likely to have poor prognosis.

References

YearCitations

Page 1